Creative Planning’s Histogen Inc. Common Stock HSTO Stock Holding History

Creative Planning’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-105	Closed	-$7K	–	2173
2020 Q1	$7K	Hold	105	–	–	﹤0.01%	1787
2019 Q4	$8K	Sell	105 -5	-5%	-$351	﹤0.01%	1924
2019 Q3	$7K	Hold	110	–	–	﹤0.01%	1918
2019 Q2	$6K	Hold	110	–	–	﹤0.01%	1955
2019 Q1	$24K	Hold	110	–	–	﹤0.01%	1832
2018 Q4	$38K	Buy	+110	New	+$85.5K	﹤0.01%	1740
2017 Q3	–	Sell	-33	Closed	-$37K	–	4035
2017 Q2	$37K	Buy	33 +3	+10%	+$3.65K	﹤0.01%	2766
2017 Q1	$35K	Buy	30 +5	+20%	+$4.83K	﹤0.01%	2731
2016 Q4	$26K	Hold	25	–	–	﹤0.01%	2906
2016 Q3	$10K	Hold	25	–	–	﹤0.01%	3545
2016 Q2	$10K	Hold	25	–	–	﹤0.01%	3269
2016 Q1	$11K	Hold	25	–	–	﹤0.01%	3196
2015 Q4	$14K	Buy	25 +20	+400%	+$14K	﹤0.01%	3087
2015 Q3	$4K	Buy	+5	New	+$4.56K	﹤0.01%	3751
2015 Q2	–	Sell	-5	Closed	-$7K	–	3328
2015 Q1	$7K	Hold	5	–	–	﹤0.01%	3416
2014 Q4	$7K	Hold	5	–	–	﹤0.01%	3349
2014 Q3	$6K	Hold	5	–	–	﹤0.01%	3228
2014 Q2	$9K	Hold	5	–	–	﹤0.01%	2956
2014 Q1	$8K	Buy	+5	New	+$10.5K	﹤0.01%	2880

Other funds holding HSTO

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

IIA

IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Creative Planning's HSTO Position: Q2 2020 in Review

Creative Planning sold out of Histogen Inc. Common Stock (HSTO) in Q2 2020, closing a stake of 105 shares — an estimated $7K sold.

Creative Planning first reported a position in HSTO in Q1 2014 and held it in 19 quarters. The position peaked at $38K in Q4 2018. 19 funds tracked by Wall St. Rank hold HSTO as of Q2 2020.

Creative Planning reported no remaining Histogen Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Creative Planning sold 105 Histogen Inc. Common Stock shares in Q2 2020, an estimated $7K.
Creative Planning first reported a position in Histogen Inc. Common Stock in Q1 2014 and held it in 19 quarters.
Creative Planning's Histogen Inc. Common Stock position peaked at $38K in Q4 2018.
19 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2020.

Based on Creative Planning's 13F filing for Q2 2020, filed 23 Jul 2020.